We are live on ! Find out more
PCM

Peregrine Capital Management Portfolio holdings

AUM $3.08B
1-Year Est. Return 29.51%
This Fund
S&P 500
This Quarter Est. Return
+6.76%
1 Year Est. Return
+29.51%
3 Year Est. Return
+95.04%
5 Year Est. Return
+107.83%
10 Year Est. Return
+715.34%
AUM
$3.38B
AUM Growth
+$66.8M
Cap. Flow
-$73.5M
Cap. Flow %
-2.18%
Top 10 Hldgs %
25.62%
Holding
354
New
31
Increased
99
Reduced
136
Closed
24

Top Buys

Rank Stock Value
1
PCOR icon
Procore
PCOR
+$38M
2
FLUT icon
Flutter Entertainment
FLUT
+$31.6M
3
SYNA icon
Synaptics
SYNA
+$10.5M
4
AAON icon
Aaon
AAON
+$8.88M
5
ROAD icon
Construction Partners
ROAD
+$8.04M

Top Sells

Rank Stock Value
1
EW icon
Edwards Lifesciences
EW
+$26.7M
2
ARES icon
Ares Management
ARES
+$22.4M
3
MA icon
Mastercard
MA
+$10.9M
4
V icon
Visa
V
+$10.7M
5
AMZN icon
Amazon
AMZN
+$9.91M

Sector Composition

Rank Sector Weight
1 Technology 28.46%
2 Financials 15.72%
3 Healthcare 15.15%
4 Consumer Discretionary 13.81%
5 Industrials 9.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
USPH icon
351
US Physical Therapy
USPH
$1.2B
-96,564
Closed -$8.17M
ATSG
352
DELISTED
Air Transport Services Group
ATSG
-218,240
Closed -$3.53M
SUM
353
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
-137,201
Closed -$5.35M
SWN
354
DELISTED
Southwestern Energy Company
SWN
-1,490
Closed -$10.6K

Similar funds

Peregrine Capital Management's Q4 2024 Portfolio in Review

As of Q4 2024, Peregrine Capital Management held 354 positions worth $3.38B, up 2% from $3.31B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Peregrine Capital Management's Q4 2024 filing shows 31 new, 99 increased, 136 reduced and 24 closed positions. Its largest new stake was Procore: 535,699 shares worth $40.1M. The largest sale was Edwards Lifesciences, an estimated $26.7M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 26% a quarter earlier, followed by Financials and Healthcare.

  • Peregrine Capital Management's largest Q4 2024 buy was Procore: 535,699 shares worth $40.1M.
  • Peregrine Capital Management added most to Synaptics in Q4 2024, an estimated $10.5M increase.
  • Peregrine Capital Management's biggest Q4 2024 reduction was Ares Management, cutting an estimated $22.4M.
  • Peregrine Capital Management fully exited Edwards Lifesciences in Q4 2024, selling an estimated $26.7M.
  • Peregrine Capital Management's ten largest holdings make up 26% of its $3.38B portfolio in Q4 2024.
  • Peregrine Capital Management opened 31 new positions and closed 24 in Q4 2024.
  • Peregrine Capital Management's portfolio value rose 2% quarter-over-quarter to $3.38B.

Based on Peregrine Capital Management's 13F filing for Q4 2024, filed 31 Jan 2025.